Differentiation therapy for the treatment of t(8;21) acute myeloid leukemia using histone deacetylase inhibitors
Key Points HDACi-mediated differentiation therapy is a potent and molecularly rational treatment strategy in t(8;21) AML.
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 131
- Institution
- Peter MacCallum Cancer Centre
External Links
Identifiers
- ORCID
- 0000-0003-0307-3574
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.